• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AOK
Click for more information
0.00% 0.3¢

AUSTRALIAN OIL COMPANY LIMITED. - Announcements

Market Cap $2.833M  ! watchlist Created with Sketch. Add to my watchlist

Australian Oil Company Limited, formerly Sacgasco Limited, is an Australia-based energy... Australian Oil Company Limited, formerly Sacgasco Limited, is an Australia-based energy company. The Company is engaged in oil and gas exploration with associated natural gas flows as a by-product in California; oil and gas exploration, production and development activities in Canada, and oil and gas exploration, appraisal, and development in the Philippines. The Company has a portfolio of gas prospects in the Sacramento Basin. The projects located in the Sacramento Basin onshore northern California include Dempsey Area, Borba, Los Medanos, Malton, Dutch Slough Gas, Rio Vista Gas and Alvares Projects. The Company has working interests in over eight gas fields in the Northern Sacramento Basin and is the operator of wells in over seven of its fields. It holds a working interest in Red Earth oil producing asset, which is located in Northern Alberta, Canada and consists of over six oilfields and associated infrastructure, which are located approximately 450 kilometers north of Edmonton.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
AOK Sacgasco's New Website and Corporate Identity04/04/17
AOK Full Year Statutory Accounts31/03/17
AOK Appendix 4G31/03/17
AOK 2016 Annual Financial Report31/03/17
AOK Full Year Reserves ReportPRICE SENSITIVE29/03/17
AOK XST: Sacramento Basin Gas UpdatePRICE SENSITIVE29/03/17
AOK $1.7 Million Share PlacementPRICE SENSITIVE28/03/17
AOK Update on Preference Share Dispute27/03/17
AOK Trading HaltPRICE SENSITIVE24/03/17
AOK AusTex Acquires New Disposal Well and AcreagePRICE SENSITIVE21/03/17
AOK Additional Gas Asset AcquisitionPRICE SENSITIVE20/03/17
AOK Trading HaltPRICE SENSITIVE17/03/17
AOK Change of Auditor16/03/17
AOK Receipt of Shareholder Redemption Notice14/03/17
AOK Farmout of Alvares Prospect InterestPRICE SENSITIVE01/03/17
AOK XST: Alvares Farmout01/03/17
AOK Appendix 4EPRICE SENSITIVE28/02/17
AOK Dempsey Farmout Increases to 32.5% of Total Well CostPRICE SENSITIVE10/02/17
AOK SGC Acquisition Adds Leases Facilities and ProductionPRICE SENSITIVE07/02/17
AOK Trading HaltPRICE SENSITIVE03/02/17
AOK Appendix 3X Philip Haydn-Slater02/02/17
AOK Appendix 3Z David McArthur02/02/17
AOK Board Change02/02/17
AOK Appendix 3Y David McArthur - 31 January 201731/01/17
AOK Appendix 3Y Gary Jeffery - 31 January 201731/01/17
AOK Appendix 3Y Andrew Childs - 31 January 201731/01/17
AOK Appendix 3B - 31 January 201731/01/17
AOK Dec 2016 Quarterly Activity and Cash Flow ReportPRICE SENSITIVE31/01/17
AOK Quarterly Activities ReportPRICE SENSITIVE31/01/17
AOK Update on Sacramento Activities - 30-Jan-17PRICE SENSITIVE30/01/17
AOK Sacgasco Secures Farm-in Partner for Dempsey ProspectPRICE SENSITIVE17/01/17
AOK Trading HaltPRICE SENSITIVE16/01/17
AOK Results of General Meeting - 11 Jan 201711/01/17
AOK Appendix 3Y Gary Jeffery - 10 January 201710/01/17
AOK Appendix 3Y Andrew Childs - 10 January 201710/01/17
AOK Appendix 3B - 10 January 201710/01/17
AOK Acquisition Agreement UpdatePRICE SENSITIVE03/01/17
AOK Notice of Meeting 11 January 201709/12/16
AOK AusTex Completes First Major AcquisitionPRICE SENSITIVE18/11/16
AOK Appendix 3X David McArthur - 16 Nov 201616/11/16
AOK Appendix 3Z Keith Martens - 16 Nov 201616/11/16
AOK Director Change16/11/16
AOK Sept 2016 Quarterly Activity and Cash Flow Report-SGC.AX PRICE SENSITIVE31/10/16
AOK Quarterly Activities Report-AOK.AX PRICE SENSITIVE31/10/16
AOK Increased Equity in Flagship Prospects - 31-Oct-16-SGC.AX PRICE SENSITIVE31/10/16
AOK Trading Halt-SGC.AX PRICE SENSITIVE27/10/16
AOK Appendix 3Y Keith Martens - 10 October 2016-SGC.AX 10/10/16
AOK Appendix 3Y Gary Jeffery - 10 October 2016-SGC.AX 10/10/16
AOK Appendix 3Y Andrew Childs - 10 October 2016-SGC.AX 10/10/16
AOK Appendix 3B - 10 October 2016-SGC.AX 10/10/16
AOK Appendix 3(B) - 21-Sep-16-SGC.AX 21/09/16
AOK MD Presentation to Good Oil Conference - 14-Sep-16-SGC.AX 14/09/16
AOK Interim Financial Report to 30 June 2016 - 13 Sep 16-SGC.AX 13/09/16
AOK Share Issue to advance JV secured - 12-Sep-16-SGC.AX PRICE SENSITIVE12/09/16
AOK Appendix 4D - Half Yearly Report-AOK.AX PRICE SENSITIVE31/08/16
AOK Half Year Reserve Report-AOK.AX PRICE SENSITIVE31/08/16
AOK Sacramento Basin Farmout Confirms AMI Value-SGC.AX PRICE SENSITIVE15/08/16
AOK Appendix 3Z Aqeel Virk - 2 August 2016-SGC.AX 02/08/16
AOK Change of Director's Interest Notice - Richard Adrey-AOK.AX 02/08/16
AOK Appendix 3B - Vesting of Shares-AOK.AX 02/08/16
AOK June 2016 Quarterly Activities & Cash Flow Report-SGC.AX PRICE SENSITIVE29/07/16
AOK Resignation of Director-SGC.AX 29/07/16
AOK Quarterly Activities Report-AOK.AX PRICE SENSITIVE29/07/16
AOK Appendix 3B - 5 July 2016-SGC.AX 05/07/16
AOK Appendix 3Y Aqeel Virk - 5 July 2016-SGC.AX 05/07/16
AOK Appendix 3Y Keith Martens - 5 July 2016-SGC.AX 05/07/16
AOK Appendix 3Y Gary Jeffery - 5 July 2016-SGC.AX 05/07/16
AOK Appendix 3Y Andrew Childs - 5 July 2016-SGC.AX 05/07/16
AOK Change of Director's Interest Notice - Richard Adrey-AOK.AX 03/06/16
AOK Appendix 3B - Lapse of Options-AOK.AX 03/06/16
AOK Results of Meeting-AOK.AX 31/05/16
AOK Presentation to Shareholders-AOK.AX 31/05/16
AOK Results of Annual General Meeting - 20-May-16-SGC.AX 20/05/16
AOK Appendix 3Y Andrew Childs - 17 May 2016-SGC.AX 17/05/16
AOK Appendix 3Y Andrew Childs - 12 May 2016-SGC.AX 12/05/16
AOK Quarterly Activities Report-AOK.AX PRICE SENSITIVE29/04/16
AOK Proxy Form-AOK.AX 29/04/16
AOK Notice of Annual General Meeting-AOK.AX 29/04/16
AOK Appendix 4G-AOK.AX 29/04/16
AOK Corporate Governance Statement-AOK.AX 29/04/16
AOK Annual Report to shareholders-AOK.AX 29/04/16
AOK Mar-16 Quarterly Activities & Cash flow Report - 29-Apr-16-SGC.AX PRICE SENSITIVE29/04/16
AOK Dispatch of 2015 Annual Report and Notice of AGM-SGC.AX 12/04/16
AOK Appendix 3Y - Keith Martens - 07-Apr-16-SGC.AX 07/04/16
AOK Appendix 3B - 07-Apr-16-SGC.AX 07/04/16
AOK Appendix 3Y - Aqeel Virk - 07-Apr-16-SGC.AX 07/04/16
AOK Appendix 3Y - Andrew Childs - 07-Apr-16-SGC.AX 07/04/16
AOK Appendix 3Y - Gary Jeffery - 07-Apr-16-SGC.AX 07/04/16
AOK Appendix 4G - 22-Mar-1622/03/16
AOK 2015 Annual Report released to the ASX - 22-Mar-1622/03/16
AOK Full Year Reserves ReportPRICE SENSITIVE01/03/16
AOK Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE29/02/16
AOK Investor Call Transcript10/02/16
AOK Details of Investor Call Updated05/02/16
AOK Details of Investor Call05/02/16
AOK Quarterly Activities ReportPRICE SENSITIVE29/01/16
AOK Dec-2015 Quarterly Activities & Cash Flow Report - 29-Jan-16PRICE SENSITIVE29/01/16
AOK Appendix 3Y Aqeel Virk - 13 January 201613/01/16
AOK Appendix 3Y Keith Martens - 13 January 201613/01/16
AOK Appendix 3Y Gary Jeffery - 13 January 201613/01/16
AOK Sacgasco's New Website and Corporate Identity
04/04/17
AOK Full Year Statutory Accounts
31/03/17
AOK Appendix 4G
31/03/17
AOK 2016 Annual Financial Report
31/03/17
AOK Full Year Reserves Report
29/03/17PRICE SENSITIVE
AOK XST: Sacramento Basin Gas Update
29/03/17PRICE SENSITIVE
AOK $1.7 Million Share Placement
28/03/17PRICE SENSITIVE
AOK Update on Preference Share Dispute
27/03/17
AOK Trading Halt
24/03/17PRICE SENSITIVE
AOK AusTex Acquires New Disposal Well and Acreage
21/03/17PRICE SENSITIVE
AOK Additional Gas Asset Acquisition
20/03/17PRICE SENSITIVE
AOK Trading Halt
17/03/17PRICE SENSITIVE
AOK Change of Auditor
16/03/17
AOK Receipt of Shareholder Redemption Notice
14/03/17
AOK Farmout of Alvares Prospect Interest
01/03/17PRICE SENSITIVE
AOK XST: Alvares Farmout
01/03/17
AOK Appendix 4E
28/02/17PRICE SENSITIVE
AOK Dempsey Farmout Increases to 32.5% of Total Well Cost
10/02/17PRICE SENSITIVE
AOK SGC Acquisition Adds Leases Facilities and Production
07/02/17PRICE SENSITIVE
AOK Trading Halt
03/02/17PRICE SENSITIVE
AOK Appendix 3X Philip Haydn-Slater
02/02/17
AOK Appendix 3Z David McArthur
02/02/17
AOK Board Change
02/02/17
AOK Appendix 3Y David McArthur - 31 January 2017
31/01/17
AOK Appendix 3Y Gary Jeffery - 31 January 2017
31/01/17
AOK Appendix 3Y Andrew Childs - 31 January 2017
31/01/17
AOK Appendix 3B - 31 January 2017
31/01/17
AOK Dec 2016 Quarterly Activity and Cash Flow Report
31/01/17PRICE SENSITIVE
AOK Quarterly Activities Report
31/01/17PRICE SENSITIVE
AOK Update on Sacramento Activities - 30-Jan-17
30/01/17PRICE SENSITIVE
AOK Sacgasco Secures Farm-in Partner for Dempsey Prospect
17/01/17PRICE SENSITIVE
AOK Trading Halt
16/01/17PRICE SENSITIVE
AOK Results of General Meeting - 11 Jan 2017
11/01/17
AOK Appendix 3Y Gary Jeffery - 10 January 2017
10/01/17
AOK Appendix 3Y Andrew Childs - 10 January 2017
10/01/17
AOK Appendix 3B - 10 January 2017
10/01/17
AOK Acquisition Agreement Update
03/01/17PRICE SENSITIVE
AOK Notice of Meeting 11 January 2017
09/12/16
AOK AusTex Completes First Major Acquisition
18/11/16PRICE SENSITIVE
AOK Appendix 3X David McArthur - 16 Nov 2016
16/11/16
AOK Appendix 3Z Keith Martens - 16 Nov 2016
16/11/16
AOK Director Change
16/11/16
AOK Sept 2016 Quarterly Activity and Cash Flow Report-SGC.AX
31/10/16PRICE SENSITIVE
AOK Quarterly Activities Report-AOK.AX
31/10/16PRICE SENSITIVE
AOK Increased Equity in Flagship Prospects - 31-Oct-16-SGC.AX
31/10/16PRICE SENSITIVE
AOK Trading Halt-SGC.AX
27/10/16PRICE SENSITIVE
AOK Appendix 3Y Keith Martens - 10 October 2016-SGC.AX
10/10/16
AOK Appendix 3Y Gary Jeffery - 10 October 2016-SGC.AX
10/10/16
AOK Appendix 3Y Andrew Childs - 10 October 2016-SGC.AX
10/10/16
AOK Appendix 3B - 10 October 2016-SGC.AX
10/10/16
AOK Appendix 3(B) - 21-Sep-16-SGC.AX
21/09/16
AOK MD Presentation to Good Oil Conference - 14-Sep-16-SGC.AX
14/09/16
AOK Interim Financial Report to 30 June 2016 - 13 Sep 16-SGC.AX
13/09/16
AOK Share Issue to advance JV secured - 12-Sep-16-SGC.AX
12/09/16PRICE SENSITIVE
AOK Appendix 4D - Half Yearly Report-AOK.AX
31/08/16PRICE SENSITIVE
AOK Half Year Reserve Report-AOK.AX
31/08/16PRICE SENSITIVE
AOK Sacramento Basin Farmout Confirms AMI Value-SGC.AX
15/08/16PRICE SENSITIVE
AOK Appendix 3Z Aqeel Virk - 2 August 2016-SGC.AX
02/08/16
AOK Change of Director's Interest Notice - Richard Adrey-AOK.AX
02/08/16
AOK Appendix 3B - Vesting of Shares-AOK.AX
02/08/16
AOK June 2016 Quarterly Activities & Cash Flow Report-SGC.AX
29/07/16PRICE SENSITIVE
AOK Resignation of Director-SGC.AX
29/07/16
AOK Quarterly Activities Report-AOK.AX
29/07/16PRICE SENSITIVE
AOK Appendix 3B - 5 July 2016-SGC.AX
05/07/16
AOK Appendix 3Y Aqeel Virk - 5 July 2016-SGC.AX
05/07/16
AOK Appendix 3Y Keith Martens - 5 July 2016-SGC.AX
05/07/16
AOK Appendix 3Y Gary Jeffery - 5 July 2016-SGC.AX
05/07/16
AOK Appendix 3Y Andrew Childs - 5 July 2016-SGC.AX
05/07/16
AOK Change of Director's Interest Notice - Richard Adrey-AOK.AX
03/06/16
AOK Appendix 3B - Lapse of Options-AOK.AX
03/06/16
AOK Results of Meeting-AOK.AX
31/05/16
AOK Presentation to Shareholders-AOK.AX
31/05/16
AOK Results of Annual General Meeting - 20-May-16-SGC.AX
20/05/16
AOK Appendix 3Y Andrew Childs - 17 May 2016-SGC.AX
17/05/16
AOK Appendix 3Y Andrew Childs - 12 May 2016-SGC.AX
12/05/16
AOK Quarterly Activities Report-AOK.AX
29/04/16PRICE SENSITIVE
AOK Proxy Form-AOK.AX
29/04/16
AOK Notice of Annual General Meeting-AOK.AX
29/04/16
AOK Appendix 4G-AOK.AX
29/04/16
AOK Corporate Governance Statement-AOK.AX
29/04/16
AOK Annual Report to shareholders-AOK.AX
29/04/16
AOK Mar-16 Quarterly Activities & Cash flow Report - 29-Apr-16-SGC.AX
29/04/16PRICE SENSITIVE
AOK Dispatch of 2015 Annual Report and Notice of AGM-SGC.AX
12/04/16
AOK Appendix 3Y - Keith Martens - 07-Apr-16-SGC.AX
07/04/16
AOK Appendix 3B - 07-Apr-16-SGC.AX
07/04/16
AOK Appendix 3Y - Aqeel Virk - 07-Apr-16-SGC.AX
07/04/16
AOK Appendix 3Y - Andrew Childs - 07-Apr-16-SGC.AX
07/04/16
AOK Appendix 3Y - Gary Jeffery - 07-Apr-16-SGC.AX
07/04/16
AOK Appendix 4G - 22-Mar-16
22/03/16
AOK 2015 Annual Report released to the ASX - 22-Mar-16
22/03/16
AOK Full Year Reserves Report
01/03/16PRICE SENSITIVE
AOK Appendix 4E and Full Year Statutory Accounts
29/02/16PRICE SENSITIVE
AOK Investor Call Transcript
10/02/16
AOK Details of Investor Call Updated
05/02/16
AOK Details of Investor Call
05/02/16
AOK Quarterly Activities Report
29/01/16PRICE SENSITIVE
AOK Dec-2015 Quarterly Activities & Cash Flow Report - 29-Jan-16
29/01/16PRICE SENSITIVE
AOK Appendix 3Y Aqeel Virk - 13 January 2016
13/01/16
AOK Appendix 3Y Keith Martens - 13 January 2016
13/01/16
AOK Appendix 3Y Gary Jeffery - 13 January 2016
13/01/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.833M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $21.46K 7.155M

Buyers (Bids)

No. Vol. Price($)
10 20533665 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 10674288 5
Last trade - 13.35pm 15/11/2024 (20 minute delay) ?
AOK (ASX) Chart

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.